HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
4505studies shown
Showing 469-480 of 4,505
Drug study icon
Not Yet RecruitingNCT07434973

Stratification and Treatment in Early Psychosis Study - PROMOTE

Official study title

ImPRoving OutcoMes in Individuals at Clinical High Risk fOr Psychosis Using Cannabidiol: a Double-blind, Randomised conTrollEd Trial

This study isn't recruiting yet.

Multiple locations, including Vienna
SchizophreniaMedication studyAges 12–35
Countries
Canada, United Kingdom, Switzerland, + 7 others
Sponsor
University of Oxford (University)
Drug study icon
Not Yet RecruitingNCT07326124

Stratification and Treatment in Early Psychosis Study -ASSIST

Official study title

Full Title: Cannabidiol Augmentation of Clozapine in Treatment Resistant Psychosis: a Double-blind, Randomised Controlled Trial

This study isn't recruiting yet.

Multiple locations, including Berlin
SchizophreniaMedication studyAges 16–50
Countries
United Kingdom, Switzerland, Germany, + 5 others
Sponsor
University of Oxford (University)
Drug study icon
Enrolling By InvitationNCT07459660

An Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

Official study title

An Open-Label Study to Assess the Long-Term Safety and Tolerability of ML007C-MA in Adult Participants With Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis

This study is by invitation only.

Multiple locations, including Anaheim
SchizophreniaMedication studyAges 55–91
Countries
United States, France, Bulgaria
Sponsor
MapLight Therapeutics
Other study type icon
CompletedACTRN12607000250437

Schizophrenia Treatment Adherence Investigation (STAI)

Official study title

Treatment review and feedback program to determine risk of poor medication adherence in patients with schizophrenia or schizoaffective disorder.

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaObservational studyAges 18+
Countries
Sponsor
Janssen-Cilag Pty Ltd

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.